Previous studies also showed that combinatory cytotoxicity of ZOL and an anti-cancer agent was linked with ZOL-mediated inhibition of P-glycoprotein functions [24] and that a combinatory use of doxorubicin and ZOL inhibited angiogenesis [26]. This evidence concerns the gene ABCB1 and cancer.